New Deal
Timothy F. Nelson
Partner at Skadden Arps Slate Meagher & Flom
Lawyer
Boston
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (38)
Key Relationships
Announcement Date
Deal Value
Select Income Reit
Government Properties Income Trust
value n/a
17 dealmakers
Red Hat
Ibm Corporation
£25,361m
95 dealmakers
Kite Pharma
Gilead Sciences
£9,302m
24 dealmakers
Express Scripts Holding Co
Cigna Corporation
£48,675m
65 dealmakers
SIRIUSDECISIONS
Forrester Research
£190m
14 dealmakers
Clementia Pharmaceuticals
IPSEN
£995m
41 dealmakers
Semma Therapeutics
Vertex Pharmaceuticals
£785m
26 dealmakers
Carbonite
OPENTEXT
£1,110m
47 dealmakers
Stemline Therapeutics
Menarini Group
£541m
44 dealmakers
Montage Resources
Southwestern Energy Company
£156m
43 dealmakers
Cersci Therapeutics
Acadia Pharmaceuticals
£717m
20 dealmakers
Akcea Therapeutics
Ionis Pharmaceuticals
£334m
36 dealmakers
Information Builders
Tibco Software
16 dealmakers
Boston Dynamics
Hyundai Motor Group
£695m
34 dealmakers
ZENETEX
Vectrus
£82m
National Holdings
B. Riley Financial
Creditsights
Fitch Group
Pandion Therapeutics
Merck & Co
£1,308m
28 dealmakers
Tremont Mortgage Trust
Rmr Mortgage Trust
£129m
STRONGBRIDGE
Xeris Pharmaceuticals
£188m
53 dealmakers
Indigo Natural Resources
£1,902m
45 dealmakers
DICERNA
Novo Nordisk
£2,452m
23 dealmakers
BOTTOMLINE
Thoma Bravo
£1,956m
30 dealmakers
Verso Corporation
BILLERUDKORSNAS
£623m
39 dealmakers
The Vertex Company
£1,587m
21 dealmakers
Antares Pharma
HALOZYME
£737m
59 dealmakers
VIACYTE
£265m
42 dealmakers
Aerie Pharmaceuticals
Alcon
£650m
58 dealmakers
Bellus Health
Glaxosmithkline
£1,614m
Iveric Bio
Astellas Pharma
£4,693m
22 dealmakers
Cti Biopharma
Swedish Orphan Biovitrum (sobi)
£1,347m
76 dealmakers
Intercept Pharmaceuticals
Alfasigma
£649m
31 dealmakers
Point Biopharma
Eli Lilly And Company
£1,152m
40 dealmakers
Mirati Therapeutics
Bristol Myers Squibb Company
£3,840m
54 dealmakers
ENGAGESMART
Vista Equity Partners
£3,288m
48 dealmakers
Ambrx
Johnson & Johnson
£1,493m
38 dealmakers
Morphosys
Novartis
£2,309m
100 dealmakers
Alpine Immune Sciences
£3,867m